COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2946: Articles 29451-29460  | Next

Improving COVID-19 Testing Efficiency using Guided Agglomerative Sampling
Minhas, F., Grammatopoulos, D., Young, L., Amin, I., Snead, D., Anderson, N., Ben-Hur, A., Rajpoot, N.
10.1101/2020.04.13.039792 — Posted: 2020-04-14
Identification of potential vaccine candidates against SARS-CoV-2, A step forward to fight novel coronavirus 2019-nCoV: A Reverse Vaccinology Approach
Gupta, E., Mishra, R. K., Niraj, R. R. K.
10.1101/2020.04.13.039198 — Posted: 2020-04-14
Detection of spreader nodes and ranking of interacting edges in Human-SARS-CoV protein interaction network
Saha, S., Chatterjee, P., Basu, S., Nasipuri, M.
10.1101/2020.04.12.038216 — Posted: 2020-04-14
Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro
Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., Xie, H., Ke, C., Gao, M., Yu, K., Liu, H., Shen, J., Tang, W., Zhang, L., Zuo, J., Jiang, H., Bai, F., Wu, Y., Ye, Y., Xu, Y.
10.1101/2020.04.13.038687 — Posted: 2020-04-14
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations
Ortiz-Fernandez, L., Sawalha, A. H.
10.1101/2020.04.06.027698 — Posted: 2020-04-14 Discussion: Onsite
ACE 2 Coding Variants: A Potential X-linked Risk Factor for COVID-19 Disease
Gibson, W. T., Evans, D. M., An, J., Jones, S. J.
10.1101/2020.04.05.026633 — Posted: 2020-04-14
Method for Active Pandemic Curve Management (MAPCM)
Odendaal, W. G.
10.1101/2020.04.06.20055699 — Posted: 2020-04-13
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
Barker, H., Parkkila, S.
10.1101/2020.04.13.038752 — Posted: 2020-04-13
Rapid, large-scale, and effective detection of COVID-19 via non-adaptive testing
Täufer, M.
10.1101/2020.04.06.028431 — Posted: 2020-04-13
Blueprint for a Pop-up SARS-CoV-2 Testing Lab
Innovative Genomics Institute SARS-CoV-2 Testing Consortium, , Doudna, J. A.
10.1101/2020.04.11.20061424 — Posted: 2020-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).